Manchester United Agree Carlos Baleba Transfer: Deal Terms

Manchester United Agree Carlos Baleba Transfer: Deal Terms

Manchester United have agreed a fee of up to £70m for Brighton midfielder Carlos Baleba, with BBC Sport, ESPN and Sky Sports all reporting the breakthrough on Friday, August 21 (BBC Sport, three days ago; ESPN, three days ago; Sky Sports, three days ago). The package is worth £65m guaranteed, with a further £5m available through add-ons.

The two clubs reached that breakthrough in negotiations on Friday evening, clearing Baleba to travel for a medical with United (BBC Sport, three days ago; ESPN, three days ago). ESPN and The Athletic reported the medical was scheduled for the following day, Saturday, August 22 (ESPN, three days ago; The Athletic, three days ago).

The August 21 reports did not confirm the outcome of that medical, and no newer reporting has surfaced to say whether it went ahead as planned. Until an official announcement from either club confirms the medical, visa approval and contract signature, the Man Utd Carlos Baleba transfer is best treated as an agreed fee rather than a finished deal.

Manchester United £70m Baleba deal: fee breakdown and contract terms

The £65m guaranteed portion sits alongside up to £5m in potential add-ons, bringing the total value of the package to as much as £70m (Sky Sports, three days ago; ESPN, three days ago). None of the reporting specifies which appearance or performance triggers apply to those add-on payments, a level of detail that rarely surfaces until deals are formally registered.

Brighton also negotiated a sell-on clause into the agreement (BBC Sport, three days ago). A sell-on clause entitles the selling club to a share of any profit if the player moves again for a higher fee later in his career. The supplied reports do not give the percentage or other terms attached to Brighton's clause, so its practical value depends entirely on what United eventually recoup for Baleba, if anything.

On personal terms, Baleba has verbally agreed to join United and is set to sign a five-year contract with an option for a further year, contingent on his visa being approved (The Athletic, three days ago; ESPN, three days ago). That visa approval, together with a completed medical, remains among the steps still needed before the transfer can be treated as complete.

Brighton Carlos Baleba transfer fee marks sharp drop from last year's valuation

United were quoted a price above £100m for Baleba last summer, a figure that led CEO Omar Berrada and director of football Jason Wilcox to walk away from talks at the time (ESPN, three days ago).

That reluctance stemmed from concern that Brighton wanted a fee close to, or beyond, the £115m Chelsea paid for Moisés Caicedo in 2023 (ESPN, three days ago). Brighton have built a reputation for extracting large fees for academy-developed and recruited midfield talent, and the Caicedo sale set the market expectation United were reportedly unwilling to meet 12 months ago.

ESPN describes the £65m guaranteed fee now agreed as a reduction of around £50m from that earlier position. The reporting does not explain what changed in Brighton's valuation over the past year (ESPN, three days ago).

United's interest in Baleba predates this agreement by close to a year. Sky Sports had been tracking the pursuit since last autumn, including an enquiry made during the January transfer window (Sky Sports, three days ago). The reports indicate United's interest carried through the year rather than disappearing after talks broke down last summer, resurfacing once the two clubs found a fee both were willing to accept.

Carlos Baleba to Manchester United: Brighton record and ankle injury

Baleba is 22, a Cameroon international, and joined Brighton from Lille in 2023 (ESPN, three days ago).

He made 92 Premier League appearances across three seasons at Brighton. The Athletic puts his total appearances across all competitions at 112 (ESPN, three days ago; The Athletic, three days ago). That workload made him a near-permanent fixture in Brighton's midfield since his arrival, and it is part of what pushed his valuation as high as it went during last summer's stalled talks.

Baleba is currently recovering from an ankle ligament injury sustained during pre-season. ESPN reported that the injury was not thought to be a major problem (ESPN, three days ago), and Sky Sports News reported he is expected to be fit around the middle of September (Sky Sports, three days ago).

That estimate falls close to United's fixtures against Manchester City on September 13 and Fulham on September 20, after which a three-week international break follows. Sky Sports reported that break would give Baleba time to settle in at Old Trafford (Sky Sports, three days ago). The mid-September window is Sky Sports' reported estimate, not a confirmed return date, and his eventual involvement would be expected to depend on how that recovery actually progresses once he joins full training.

Baleba would become United's third midfield addition of the summer, following the arrivals of Andrey Santos and Youri Tielemans (ESPN, three days ago). That represents a significant rebuild of the position in a single window, and it puts additional weight on getting Baleba registered and fit before the squad settles into its autumn rhythm.

What's confirmed and what remains unverified as of August 24

The fee structure, sell-on clause and contract terms outlined above reflect the details reported on August 21. The supplied reporting does not confirm whether Baleba's medical, scheduled for August 22, took place, whether his visa has been approved, or whether his contract has actually been signed.

His fitness timeline is a separate matter from that paperwork. Even once the transfer is completed, his appearances for United would be expected to depend on his recovery from the ankle injury, with Sky Sports' report placing his expected fitness date around the middle of September (Sky Sports, three days ago).

An official announcement from Manchester United or Brighton would confirm completion of the transfer, along with any update on the medical outcome and visa clearance that current reporting has not yet addressed.